Sue is based in London and brings to Novitious her more than 30 years of experience in biopharmaceuticals product strategy, Venture Capital, M&A and strategic consulting.

Most recently, Sue provided interim Director level support for two Top 10 pharmaceutical companies in the areas of launch planning and competitor intelligence for cardiovascular / metabolic, neuroscience, oncology and respiratory franchises. Prior to this, Sue was a VP with Versant Ventures and Wood Mackenzie, and previously a member of the Roche Partnering M&A team.

She has in-depth experience of aligning scientific and commercial considerations across a broad range of indications and therapeutic areas.